Radiant Innovation

Radiant Innovation Accounts Payable

The Accounts Payable of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is 26.96 M TWD. In the previous year, Accounts Payable was 31.03 M TWD — a change of -13.11% (lower).

Accounts Payable

26.96 MTWD

YoY

-13.11%

Last updated:

Accounts Payable of Radiant Innovation is 2025 26.96 M TWD. Accounts Payable of Radiant Innovation was 2024 31.03 M TWD. It decreases by -13.11% lower compared to the previous year.

The Radiant Innovation Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2018
74.30 M TWD
Jan 1, 2019
77.60 M TWD
Jan 1, 2020
233.86 M TWD
Jan 1, 2021
57.79 M TWD
Jan 1, 2022
34.63 M TWD
Jan 1, 2023
20.87 M TWD
Jan 1, 2024
31.03 M TWD
Jan 1, 2025
26.96 M TWD
The Radiant Innovation Accounts Payable history
YEARAccounts PayableYoY
26.96 MTWD-13.11%
31.03 MTWD+48.70%
20.87 MTWD-39.73%
34.63 MTWD-40.08%
57.79 MTWD-75.29%
233.86 MTWD+201.37%
77.60 MTWD+4.43%
74.30 MTWD-12.97%
85.38 MTWD+7.24%
79.61 MTWD-4.85%
83.67 MTWD-20.31%
105.00 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Accounts Payable of Radiant Innovation is 26.96 M TWD in 2025.

Accounts Payable of Radiant Innovation changed from 31.03 M TWD to 26.96 M TWD, representing a -13.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Radiant Innovation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Radiant Innovation

All Key Metrics — Radiant Innovation